• National
  • International
  • Analysis
  • Opinion
  • Business
  • Personal Finance
  • Sports
  • Technology
  • Lifestyle
  • Entertainment
  • National
  • International
  • Analysis
  • Opinion
  • Business
  • Personal Finance
  • Sports
  • Technology
  • Lifestyle
  • Entertainment
Authors
You have successfully subscribed the newsletter.
Another Alzheimer’s drug fails in late-stage trials – what now?

Another Alzheimer’s drug fails in late-stage trials – what now?

Around 55 million people, globally, have dementia – the most common type being Alzheimer’s disease. Unfortunately, there is no cure for the memory-robbing disease
Latest Stories

Authors
Select Language
English

Share this article

If you liked this article share it with your friends.
they will thank you later

Facebook
Twitter
Whatsapp

Copied!